Results 141 to 150 of about 5,754 (180)
Some of the next articles are maybe not open access.
PGT-M for Couples with a Single-Gene Disorder
2020For all patients considering fertility, a detailed family history should be ascertained from the patient and partner (if there is a partner). Ideally, this would be a full pedigree of family members up to three generations from the individual. This entails getting the medical history of parents and sibs (first degree); aunts, uncles, and grandparents ...
openaire +1 more source
69. IMPROVED IVF SUCCESS OF COMBINED PGT-M AND PGT-A APPLICATIONS
Reproductive BioMedicine Online, 2019Introduction Preimplantation Genetic Testing (PGT) has been performed since 1989 and utilized in the diagnosis of all genetic conditions at preimplantation stage ( 1 ). In the previous years, only a disorder could be diagnosed with the use of multiplex nested PCR in PGT applications.
E. Unsal +4 more
openaire +1 more source
Human Reproduction
Abstract Study question Is there a difference in cycle outcomes when embryos are tested solely for monogenic diseases (PGT-M) or a combination of PGT-M and chromosomal abnormalities (PGT-A)? Summary answer The Haploseek combining PGT ...
M Youngster +10 more
openaire +1 more source
Abstract Study question Is there a difference in cycle outcomes when embryos are tested solely for monogenic diseases (PGT-M) or a combination of PGT-M and chromosomal abnormalities (PGT-A)? Summary answer The Haploseek combining PGT ...
M Youngster +10 more
openaire +1 more source
49. Molecular PGT-M for VUS in the genomic era: to do or not to do?
Reproductive BioMedicine Online, 2019Introduction The new chromosomal microarray CMA technology, allows the identification of genetic defects in many disorders that would previously have escaped detection. Alongside the benefits, it exposes us to copy number variants (CNV) whose pathogenic significance is unclear "Variants of unknown significance" (VUS).
K. Rotshenker Olshinka +7 more
openaire +1 more source
A Qualitative Exploration of Oncology Clinician’s Needs for PGT-M Discussions in Clinical Practice
Journal of Adolescent and Young Adult OncologyPurpose: Oncology clinicians are appropriately positioned to facilitate discussions of assisted reproductive technologies including preimplantation genetic testing for monogenic disease (PGT-M), in the context of cancer treatment or surveillance.
Davia A. Schioppo +3 more
openaire +2 more sources
Strategies and Indications for Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
2020Preimplantation genetic testing for monogenic disorders (PGT-M) is now an established clinical procedure performed for some indications that have never been considered for prenatal diagnosis, such as common late-onset disorders or preimplantation HLA typing.
Anver Kuliev +2 more
openaire +1 more source
Good laboratory practice for PGT-M: Turkish Society of Reproductive Medicine guidelines
Reproductive BioMedicine OnlineThis guideline was prepared by the Turkish Society of Reproductive Medicine to define the conditions and requirements for an outsourced preimplantation genetic testing (PGT) programme in line with the experience and needs of practitioners. This guideline is intended to be a reference document for assisted reproductive technology centres, genetic ...
Evrim Unsal +24 more
openaire +2 more sources
PGT-M FOR DE NOVO VARIANTS: DELETION BREAKPOINT SEQUENCING
Fertility and Sterility, 2023Avner Hershlag +2 more
openaire +1 more source
Journal of Genetic Counseling
AbstractIncreasing numbers of fertility patients use preimplantation genetic testing for monogenic conditions (PGT‐M) during in vitro fertilization (IVF). While PGT‐M is primarily used to avoid implanting embryos with a monogenic condition, patients can request to transfer an embryo with the monogenic condition (positive embryo transfer), especially in
Silvia Gunderson, Jazmine Gabriel
openaire +2 more sources
AbstractIncreasing numbers of fertility patients use preimplantation genetic testing for monogenic conditions (PGT‐M) during in vitro fertilization (IVF). While PGT‐M is primarily used to avoid implanting embryos with a monogenic condition, patients can request to transfer an embryo with the monogenic condition (positive embryo transfer), especially in
Silvia Gunderson, Jazmine Gabriel
openaire +2 more sources
IMPACT OF EMBRYO BIOPSY FOR PGT-M TESTING ON PREGNANCY OUTCOMES
Fertility and Sterility, 2023Evelina Manvelyan +2 more
openaire +1 more source

